Biomarker
Biomarker is an intervention with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Biomarkers in Perioperative Management
Liver Immunosuppression Free Trial
Characterization of Heart Failure With Preserved Ejection Fraction
Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest
Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operations.
Clinical Trials (11)
Biomarkers in Perioperative Management
Liver Immunosuppression Free Trial
Characterization of Heart Failure With Preserved Ejection Fraction
Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest
Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operations.
Heparin Binding Protein in Early Sepsis Diagnosis
CNS Infections Effect on the Inner Ear
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Biomarker Study to Diagnose Alzheimer's Disease
A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours
Biomarker in Lung Diseases
All 11 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 11